Theralase Announces Upcoming Shareholder Meeting
PremiumCompany AnnouncementsTheralase Announces Upcoming Shareholder Meeting
2M ago
Theralase’s Rutherrin® Enhances Chemotherapy Success
Premium
Company Announcements
Theralase’s Rutherrin® Enhances Chemotherapy Success
2M ago
Theralase’s Ruvidar Boosts Cancer Drug Efficacy
Premium
Company Announcements
Theralase’s Ruvidar Boosts Cancer Drug Efficacy
3M ago
TLT Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsTLT Upcoming Earnings Report: What to Expect?
3M ago
Theralase Strengthens Team to Advance Cancer Study
Premium
Company Announcements
Theralase Strengthens Team to Advance Cancer Study
4M ago
Theralase Secures Funds for Cancer Research
Premium
Company Announcements
Theralase Secures Funds for Cancer Research
4M ago
Theralase® Releases FY2022 Audited Financial Statements
PremiumPress ReleasesTheralase® Releases FY2022 Audited Financial Statements
1y ago
Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company
Premium
Press Releases
Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company
2y ago
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium
Premium
Press Releases
Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100